553 related articles for article (PubMed ID: 23720450)
1. Breast fine-needle aspiration cytology performance in the high-risk screening population: a study of BRCA1/BRCA2 mutation carriers.
Georgieva RD; Obdeijn IM; Jager A; Hooning MJ; Tilanus-Linthorst MM; van Deurzen CH
Cancer Cytopathol; 2013 Oct; 121(10):561-7. PubMed ID: 23720450
[TBL] [Abstract][Full Text] [Related]
2. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
Kocjan G
Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.
Fakkert IE; Jansen L; Meijer K; Kok T; Oosterwijk JC; Mourits MJ; de Bock GH
Breast Cancer Res Treat; 2011 Aug; 129(1):157-64. PubMed ID: 21373873
[TBL] [Abstract][Full Text] [Related]
4. Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers.
Metcalfe K; Lynch HT; Ghadirian P; Tung N; Kim-Sing C; Olopade OI; Domchek S; Eisen A; Foulkes WD; Rosen B; Vesprini D; Sun P; Narod SA
Breast Cancer Res Treat; 2011 May; 127(1):287-96. PubMed ID: 21221768
[TBL] [Abstract][Full Text] [Related]
5. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions.
Garg S; Mohan H; Bal A; Attri AK; Kochhar S
Diagn Cytopathol; 2007 Nov; 35(11):681-9. PubMed ID: 17924407
[TBL] [Abstract][Full Text] [Related]
7. Fine-needle aspiration cytology vs. core biopsy in the diagnosis of breast lesions.
Berner A; Davidson B; Sigstad E; Risberg B
Diagn Cytopathol; 2003 Dec; 29(6):344-8. PubMed ID: 14648793
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A review.
Willems SM; van Deurzen CH; van Diest PJ
J Clin Pathol; 2012 Apr; 65(4):287-92. PubMed ID: 22039282
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of fine-needle aspiration cytology in the diagnosis of breast cancer a single-center retrospective study from Turkey with cytohistological correlation in 733 cases.
Aker F; Gümrükçü G; Onomay BÇ; Erkan M; Gürleyik G; Kiliçoğlu G; Karagüllü H
Diagn Cytopathol; 2015 Dec; 43(12):978-86. PubMed ID: 26466750
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.
Heemskerk-Gerritsen BA; Brekelmans CT; Menke-Pluymers MB; van Geel AN; Tilanus-Linthorst MM; Bartels CC; Tan M; Meijers-Heijboer HE; Klijn JG; Seynaeve C
Ann Surg Oncol; 2007 Dec; 14(12):3335-44. PubMed ID: 17541692
[TBL] [Abstract][Full Text] [Related]
11. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
12. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
[TBL] [Abstract][Full Text] [Related]
13. Eleven years of experience reveals that fine-needle aspiration cytology is still a useful method for preoperative diagnosis of breast carcinoma.
He Q; Fan X; Yuan T; Kong L; Du X; Zhuang D; Fan Z
Breast; 2007 Jun; 16(3):303-6. PubMed ID: 17287118
[TBL] [Abstract][Full Text] [Related]
14. Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.
Narod SA; Lubinski J; Ghadirian P; Lynch HT; Moller P; Foulkes WD; Rosen B; Kim-Sing C; Isaacs C; Domchek S; Sun P;
Lancet Oncol; 2006 May; 7(5):402-6. PubMed ID: 16648044
[TBL] [Abstract][Full Text] [Related]
15. Should fine-needle aspiration cytology be the first choice diagnostic modality for assessment of all nonpalpable breast lesions? The experience of a breast cancer screening center in Alexandria, Egypt.
Abdel-Hadi M; Abdel-Hamid GF; Abdel-Razek N; Fawzy RK
Diagn Cytopathol; 2010 Dec; 38(12):880-9. PubMed ID: 20049973
[TBL] [Abstract][Full Text] [Related]
16. Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?
Bernholtz S; Laitman Y; Kaufman B; Shimon-Paluch S; Friedman E
Breast Cancer Res Treat; 2012 Apr; 132(2):669-73. PubMed ID: 22113258
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer.
Kaas R; Verhoef S; Wesseling J; Rookus MA; Oldenburg HS; Peeters MJ; Rutgers EJ
Ann Surg; 2010 Mar; 251(3):488-92. PubMed ID: 20134318
[TBL] [Abstract][Full Text] [Related]
18. Role of fine-needle aspiration cytology and core biopsy in the preoperative diagnosis of screen-detected breast carcinoma.
Lieske B; Ravichandran D; Wright D
Br J Cancer; 2006 Jul; 95(1):62-6. PubMed ID: 16755293
[TBL] [Abstract][Full Text] [Related]
19. Concordance of breast fine needle aspiration cytology interpretation with subsequent surgical pathology: An 18-year review from a single sub-Saharan African institution.
McHugh KE; Bird P; Sturgis CD
Cytopathology; 2019 Sep; 30(5):519-525. PubMed ID: 30929288
[TBL] [Abstract][Full Text] [Related]
20. ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers.
Adem C; Soderberg CL; Hafner K; Reynolds C; Slezak JM; Sinclair CS; Sellers TA; Schaid DJ; Couch F; Hartmann LC; Jenkins RB
Genes Chromosomes Cancer; 2004 Sep; 41(1):1-11. PubMed ID: 15236312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
